IDEAYA Biosciences (IDYA) Gains from Investment Securities (2018 - 2025)

IDEAYA Biosciences has disclosed Gains from Investment Securities across 8 years of filings, most recently posting $5.3 million for Q4 2025.

• Gains from Investment Securities for Q4 2025 came in at $5.3 million, up 230.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.5 million (down 58.18% YoY), and the FY2025 annual result was $11.1 million, up 43.85% from the prior year.
• Gains from Investment Securities came in at $5.3 million for Q4 2025 at IDEAYA Biosciences, up from $4.0 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $16.9 million in Q4 2023 to a low of -$1.2 million in Q4 2022.
• The 5-year median for Gains from Investment Securities is $1.9 million (2023), against an average of $3.1 million.
• Peak annual rise in Gains from Investment Securities reached 176826.8% in 2021, while the deepest fall reached 95.51% in 2021.
• IDEAYA Biosciences' Gains from Investment Securities stood at $134619.0 in 2021, then slumped by 991.4% to -$1.2 million in 2022, then surged by 1508.33% to $16.9 million in 2023, then plunged by 90.53% to $1.6 million in 2024, then soared by 230.38% to $5.3 million in 2025.
• The last three Gains from Investment Securities figures came in at $5.3 million (Q4 2025), $4.0 million (Q3 2025), and $3.8 million (Q2 2025), per Business Quant data.